Syndax Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+1.25 K	0.7%	$20.03	+$25 K
Sells	2	-189 K	99.3%	$19.83	-$3.74 M
Net	-1	-187 K	-98.7%		-$3.72 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Michael A. Metzger	Chief Executive Officer, Director	$7.63 M			Feb 7, 2024
Steve M. Sabus	Chief Commercial Officer	$5.69 M			Dec 5, 2022
Catherine Madigan	Chief Medical Officer	$2.84 M			Feb 2, 2023
Keith A. Goldan	Chief Financial Officer	$2.61 M	+$25 K	+0.97%	Jun 14, 2024
Dennis Podlesak	Director	$2.59 M			Feb 7, 2024
Neil Gallagher	President, Head of R&D	$2.42 M			Feb 7, 2024
William Meury	Director	$1.19 M	-$1.7 M	-58.8%	Feb 7, 2024
Keith Katkin	Director	$1.19 M			Feb 7, 2024
Jennifer Jarrett	Director	$1.19 M			Feb 7, 2024
Pierre Legault	Director	$1.19 M			Feb 7, 2024
Martin H. Huber Jr.	Director	$895 K			Feb 7, 2024
Michael L. Meyers	SVP, Chief Medical Officer	$874 K			Feb 2, 2022
Aleksandra Rizo	Director	$780 K			May 15, 2024
Briggs Morrison	Director	$636 K	-$2.04 M	-76.3%	Feb 7, 2024
Fabrice Egros	Director	$584 K			Feb 2, 2022
Alexander Nolte	Chief Accounting Officer	$439 K			Feb 2, 2023
Peter Ordentlich	Chief Scientific Officer				Feb 15, 2023

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership